Overall rank by patents
#25,862
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, active 2015–2017. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y10T (TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION).
The verdict
Bizerba holds 10 US patents across 10 technology areas, rank #25,862 of 50,000 tracked assignees.
Bizerba Gmbh & Co. KG has been granted 10 US utility patents between 2015 and 2017, placing Bizerba Gmbh & Co. KG at rank #25,862 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.7 claims per patent with primary concentration in Y10T (TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION). As a Foreign Corporation, Bizerba Gmbh & Co. KG is one of the more focused assignees in the PatentsView dataset. By volume, Bizerba sits between BIOS SRL (10 patents, rank #25,858) and BMC Co., Ltd. (10 patents, rank #25,866) - the closest US assignees by grant volume. The composite Innovation Score of 28.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 10 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Bizerba Gmbh & Co. KG's 14.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bizerba Gmbh & Co. KG against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
BIOS SRL
10 patents
BIOSEARCH TECHNOLOGIES, INC.
10 patents
BIOVEST INTERNATIONAL, INC.
10 patents
BIRKO CORPORATION
10 patents
BLACKTHORN THERAPEUTICS, INC.
10 patents
BLOX, LLC
10 patents
BLUEPLANET INC.
10 patents
BMC CO., LTD.
10 patents
BIZERBA GMBH & CO. KG
10 patents
What this shows Bizerba holds 10 patents at rank #25,862, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Bizerba's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 73% higher than 27% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 20.0% |
| 2016 | 5 | 50.0% |
| 2017 | 3 | 30.0% |
Top 10 of 10 technology areas
Overall rank by patents
#25,862
Across all tracked assignees
28.3 out of 100
How to use this portfolio
Bizerba's 10 grants land it in the top 73% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.